from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0208c/-

LFCtreatmentdescriptionclass of inhibitor

-0.428

Amikacinug/mL Amikacintranslation

0.139

Cap5-10ug/mL Capreomycintranslation

0.161

Rox10-50 ug/mL Roxithromycintranslation

-0.586

SM2-5 ug/mL Streptomycintranslation

-1.382

Tet5-10 ug/mL Tetracyclinetranslation

-0.239

Rif0.2-5ug/mL Rifampicintranscription

-0.344

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.923

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.538

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.377

CPZ10-50 ug/mL Chlorpromazinerespiration

0.537

Clofazimine10-13 ug/mL Clofaziminerespiration

0.413

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-3.197

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.122

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.551

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.709

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.203

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.063

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.043

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.380

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-2.331

KCN5-20 ug/mL Potassium cyaniderespiration

-0.019

NaN30.2-2 mM Sodium aziderespiration

0.568

Nigericin50 uM Nigericinrespiration

-0.406

TRC10-150 ug/mL Triclosanrespiration

-0.358

TRZ10-25 ug/mL Thioridazinerespiration

-1.417

Valinomycin0.5-10 uM Valinomycinrespiration

1.156

ZnSO42 mM ZnSO4respiration

-0.528

menadione6-10 ug/mL Menadionerespiration

-0.600

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.172

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.013

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.034

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.642

NRP_1Non-replicating persistence stage 1dosRassociated

1.324

Amp0.2mg/mL AmpicillincellWall

0.810

Cephalexin20-100 ug/mL CephalexincellWall

0.708

Cerulenin0.32-5 ug/mL CerulenincellWall

0.316

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.772

EMB10-20 ug/mL EthambutolcellWall

1.486

Eta12-40 ug/mL EthionamidecellWall

1.363

INH0.2-0.4 ug/mL IsoniazidcellWall

1.692

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.258

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.090

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.083

BZA0.12 mg/mL BenzamidearomaticAmides

-0.519

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.657

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.193

H2O24 mM hydrogen peroxideDNAdamaging

-0.241

Levo10 ug/mL LevofloxacinDNAdamaging

-0.026

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.541

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.345

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.086

UVUV-irradiationDNAdamaging

-0.643

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.128

Antimycin12.5-50 ug/mL Antimycin A?

0.584

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.021

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.045

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.974

PA8240.2-2 ug/mL PA-824?

-0.929

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.775

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.367

Verapamil50 uM Verapamil?

-0.113

mercaptoethanol2 mM 2-Mercaptoethanol?

0.630

methoxatin10-20 ug/mL Methoxatin?